Investigating new candidate vaccine approaches for different disease targets: a day in the life of Kate Broderick
This International Women’s Day (8 March), we are exploring what a typical (or not so typical!) day entails, the best and most challenging aspects of the job, and the diversity of roles within the nanotechnology field. In this interview, we hear from Kate Broderick, the Senior Vice President of R&D at Inovio Pharmaceuticals (CA, USA). Kate Broderick is the Senior Vice President of R&D at Inovio Pharmaceuticals, where she oversees a diverse group of stakeholders who perform the early research into new candidate vaccine approaches for different disease targets. Broderick moved to the USA in 2002 from her home in...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
